Revenue Summary of Changjiang Pharmaceutical Group Co., Ltd.

Changjiang Pharmaceutical Group Co., Ltd.'s latest annual revenue in 2023 was 1.19 Billion CNY , down -25.86% from previous year.
Changjiang Pharmaceutical Group Co., Ltd.'s latest quarterly revenue in 2024 Q2 was 13.86 Million CNY , down -76.53% from previous quarter.
Changjiang Pharmaceutical Group Co., Ltd. reported a annual revenue of 1.61 Billion CNY in annual revenue 2022, down -31.61% from previous year.
Changjiang Pharmaceutical Group Co., Ltd. reported a annual revenue of 2.36 Billion CNY in annual revenue 2021, up 94.48% from previous year.
Changjiang Pharmaceutical Group Co., Ltd. reported a quarterly revenue of 59.09 Million CNY for 2024 Q1, down -66.37% from previous quarter.
Changjiang Pharmaceutical Group Co., Ltd. reported a quarterly revenue of 13.86 Million CNY for 2024 Q2, down -76.53% from previous quarter.

Annual Revenue Chart of Changjiang Pharmaceutical Group Co., Ltd. (2023 - 2009)

Historical Annual Revenue of Changjiang Pharmaceutical Group Co., Ltd. (2023 - 2009)

Year	Revenue	Revenue Growth
2023	1.19 Billion CNY	-25.86%
2022	1.61 Billion CNY	-31.61%
2021	2.36 Billion CNY	94.48%
2020	1.21 Billion CNY	67.45%
2019	725.31 Million CNY	-17.67%
2018	881.02 Million CNY	18.39%
2017	744.15 Million CNY	216.84%
2016	234.86 Million CNY	22.81%
2015	191.25 Million CNY	-21.43%
2014	243.42 Million CNY	-4.68%
2013	255.38 Million CNY	13.37%
2012	225.27 Million CNY	0.94%
2011	223.18 Million CNY	25.66%
2010	177.6 Million CNY	38.62%
2009	128.13 Million CNY	0.0%

Year	Revenue	Revenue Growth
2024 Q3	26.59 Million CNY	91.76%
2024 Q1	59.09 Million CNY	-66.37%
2024 Q2	13.86 Million CNY	-76.53%
2023 Q1	136.79 Million CNY	-29.0%
2023 FY	1.19 Billion CNY	-25.86%
2023 Q4	175.69 Million CNY	-67.81%
2023 Q3	545.85 Million CNY	60.91%
2023 Q2	339.22 Million CNY	147.98%
2022 Q3	430.79 Million CNY	-3.51%
2022 FY	1.61 Billion CNY	-31.61%
2022 Q4	192.67 Million CNY	-55.27%
2022 Q2	446.44 Million CNY	-18.14%
2022 Q1	545.4 Million CNY	0.32%
2021 Q2	512.48 Million CNY	-34.73%
2021 Q4	543.66 Million CNY	4.42%
2021 FY	2.36 Billion CNY	94.48%
2021 Q3	520.63 Million CNY	1.59%
2021 Q1	785.14 Million CNY	37.89%
2020 Q1	125.51 Million CNY	-9.6%
2020 FY	1.21 Billion CNY	67.45%
2020 Q4	569.4 Million CNY	106.0%
2020 Q2	243.17 Million CNY	93.74%
2020 Q3	276.4 Million CNY	13.66%
2019 Q3	128.64 Million CNY	-35.08%
2019 FY	725.31 Million CNY	-17.67%
2019 Q1	259.67 Million CNY	46.95%
2019 Q2	198.14 Million CNY	-23.69%
2019 Q4	138.84 Million CNY	7.93%
2018 Q1	152.34 Million CNY	-37.29%
2018 FY	881.02 Million CNY	18.39%
2018 Q4	176.71 Million CNY	-32.74%
2018 Q3	262.71 Million CNY	-9.17%
2018 Q2	289.24 Million CNY	89.87%
2017 Q4	242.93 Million CNY	13.58%
2017 FY	744.15 Million CNY	216.84%
2017 Q3	213.88 Million CNY	-2.51%
2017 Q2	219.38 Million CNY	222.9%
2017 Q1	67.94 Million CNY	7.87%
2016 Q4	62.98 Million CNY	7.29%
2016 FY	234.86 Million CNY	22.81%
2016 Q3	58.7 Million CNY	14.34%
2016 Q2	51.34 Million CNY	-16.97%
2016 Q1	61.83 Million CNY	45.2%
2015 FY	191.25 Million CNY	-21.43%
2015 Q4	42.58 Million CNY	9.93%
2015 Q3	38.73 Million CNY	-24.73%
2015 Q2	51.46 Million CNY	-11.98%
2015 Q1	58.46 Million CNY	-10.19%
2014 Q2	63.65 Million CNY	9.16%
2014 Q1	58.31 Million CNY	-22.54%
2014 FY	243.42 Million CNY	-4.68%
2014 Q4	65.09 Million CNY	15.5%
2014 Q3	56.36 Million CNY	-11.45%
2013 FY	255.38 Million CNY	13.37%
2013 Q2	69.88 Million CNY	16.88%
2013 Q4	75.28 Million CNY	49.3%
2013 Q3	50.42 Million CNY	-27.85%
2013 Q1	59.79 Million CNY	0.0%
2012 FY	225.27 Million CNY	0.94%
2011 FY	223.18 Million CNY	25.66%
2010 FY	177.6 Million CNY	38.62%
2009 FY	128.13 Million CNY	0.0%

Peer Revenue Comparison of Changjiang Pharmaceutical Group Co., Ltd.

Name	Revenue	Revenue Difference
Shenzhen Neptunus Bioengineering Co., Ltd.	36.41 Billion CNY	96.712%
Anhui Fengyuan Pharmaceutical Co., Ltd.	4.27 Billion CNY	71.99%
Dong-E-E-Jiao Co.,Ltd.	4.71 Billion CNY	74.602%
Livzon Pharmaceutical Group Inc.	12.27 Billion CNY	90.247%
Hainan Haiyao Co., Ltd.	1.45 Billion CNY	17.819%
Tus-Pharmaceutical Group Co., Ltd.	395.92 Million CNY	-202.474%
Jilin Aodong Pharmaceutical Group Co., Ltd.	3.44 Billion CNY	65.279%
Changchun High-Tech Industries (Group) Inc.	14.46 Billion CNY	91.718%
Apeloa Pharmaceutical Co.,Ltd	11.47 Billion CNY	89.563%
PKU HealthCare Corp.,Ltd.	2.19 Billion CNY	45.411%
Chengdu Huasun Technology Group Inc., Ltd.	1 Billion CNY	-19.353%
Dezhan Healthcare Company Limited	498.08 Million CNY	-140.432%
Jinling Pharmaceutical Company Limited	2.78 Billion CNY	57.011%
Jiuzhitang Co., Ltd.	2.91 Billion CNY	58.978%
Huapont Life Sciences Co., Ltd.	11.59 Billion CNY	89.671%
Zhejiang Jingxin Pharmaceutical Co., Ltd.	3.95 Billion CNY	69.698%
Shandong Wohua Pharmaceutical Co., Ltd.	894.31 Million CNY	-33.908%
Hengkang Medical Group Co., Ltd.	3.59 Billion CNY	66.646%
Guangdong Zhongsheng Pharmaceutical Co., Ltd.	2.61 Billion CNY	54.126%
Qianjiang Yongan Pharmaceutical Co., Ltd.	962.8 Million CNY	-24.383%
Shenzhen Hepalink Pharmaceutical Group Co., Ltd.	5.42 Billion CNY	77.912%
Jinhe Biotechnology CO., LTD.	2.17 Billion CNY	44.918%
Teyi Pharmaceutical Group Co.,Ltd	1.06 Billion CNY	-12.214%
Kunming Longjin Pharmaceutical Co., Ltd.	86.62 Million CNY	-1282.507%
Beijing Aosaikang Pharmaceutical Co., Ltd.	1.44 Billion CNY	17.035%
Chengdu Kanghong Pharmaceutical Group Co., Ltd	3.95 Billion CNY	69.739%
Anhui Huangshan Capsule Co., Ltd.	458.36 Million CNY	-161.266%
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd	980.82 Million CNY	-22.097%
Zhuhai Rundu Pharmaceutical Co., Ltd.	1.29 Billion CNY	7.301%
Huaren Pharmaceutical Co., Ltd.	1.63 Billion CNY	26.811%
Tianjin Ringpu Bio-Technology Co.,Ltd.	2.24 Billion CNY	46.75%
Shanxi Zhendong Pharmaceutical Co.,Ltd	3.62 Billion CNY	66.973%
Fuan Pharmaceutical (Group) Co., Ltd.	2.64 Billion CNY	54.771%
Hybio Pharmaceutical Co., Ltd.	431.38 Million CNY	-177.609%
Baotou Dongbao Bio-Tech Co.,Ltd	974.51 Million CNY	-22.888%
Hunan Er-Kang Pharmaceutical Co., Ltd	1.76 Billion CNY	32.31%
Zhejiang Garden Bio-chemical High-tech Co., Ltd.	1.09 Billion CNY	-9.401%
Fujian Cosunter Pharmaceutical Co., Ltd.	422.71 Million CNY	-183.303%
Beijing Science Sun Pharmaceutical Co., Ltd.	476.56 Million CNY	-151.288%
Zhejiang Xinguang Pharmaceutical Co., Ltd.	270.39 Million CNY	-342.886%
Hainan Poly Pharm. Co., Ltd	1.3 Billion CNY	8.196%
Jiangxi Synergy Pharmaceutical Co., Ltd.	722.13 Million CNY	-65.836%
Wuhan Hiteck Biological Pharma Co.,Ltd	602.28 Million CNY	-98.837%
Shandong Xinhua Pharmaceutical Company Limited	8 Billion CNY	85.047%
Zhejiang Tianyu Pharmaceutical Co., Ltd.	2.52 Billion CNY	52.614%
PharmaBlock Sciences (Nanjing), Inc.	1.72 Billion CNY	30.584%
Jinghua Pharmaceutical Group Co., Ltd.	1.49 Billion CNY	19.651%
Zhejiang Hisoar Pharmaceutical Co., Ltd.	2.17 Billion CNY	44.861%
Betta Pharmaceuticals Co., Ltd.	2.45 Billion CNY	51.243%
Tibet AIM Pharm. Inc.	667.03 Million CNY	-79.534%
Shenzhen Kangtai Biological Products Co., Ltd.	3.47 Billion CNY	65.562%
Shandong Shanda Wit Science and Technology Co., Ltd.	2.48 Billion CNY	51.792%
Pacific Shuanglin Bio-pharmacy Co., LTD	2.32 Billion CNY	48.574%
Zhejiang AngLiKang Pharmaceutical CO.,LTD.	1.62 Billion CNY	26.343%
Xiamen Kingdomway Group Company	3.1 Billion CNY	61.401%
ShanXi C&Y Pharmaceutical Group Co., Ltd.	799.3 Million CNY	-49.825%
Walvax Biotechnology Co., Ltd.	4.11 Billion CNY	70.889%
Sunflower Pharmaceutical Group Co.,Ltd	5.63 Billion CNY	78.736%
Harbin Gloria Pharmaceuticals Co., Ltd	2.58 Billion CNY	53.761%
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.	24.73 Billion CNY	95.159%
Hunan Hansen Pharmaceutical Co., Ltd.	955.53 Million CNY	-25.33%
Changzhou Qianhong Biopharma CO.,LTD	1.79 Billion CNY	33.241%
Shenzhen Weiguang Biological Products Co., Ltd.	1.04 Billion CNY	-14.216%
Honz Pharmaceutical Co., Ltd.	739.56 Million CNY	-61.927%
Northeast Pharmaceutical Group Co., Ltd.	8.16 Billion CNY	85.327%
Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd	1.46 Billion CNY	18.125%
Guizhou Xinbang Pharmaceutical Co., Ltd.	6.46 Billion CNY	81.464%
Tianjin Lisheng Pharmaceutical Co.,Ltd.	1.13 Billion CNY	-5.964%
Zhejiang Yatai Pharmaceutical Co., Ltd.	420.64 Million CNY	-184.698%
Zhejiang NHU Company Ltd.	15.11 Billion CNY	92.078%
ApicHope Pharmaceutical Co., Ltd	2.5 Billion CNY	52.163%
Shanghai Kaibao Pharmaceutical CO.,Ltd	1.59 Billion CNY	24.873%
Beijing SL Pharmaceutical Co., Ltd.	1.01 Billion CNY	-17.597%
Yunnan Baiyao Group Co.,Ltd	38.9 Billion CNY	96.921%
Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD	1.08 Billion CNY	-10.88%
Anhui Sunhere Pharmaceutical Excipients Co.,Ltd.	839.25 Million CNY	-42.693%
Guangdong Lifestrong Pharmacy Co., Ltd.	292.39 Million CNY	-309.567%
Huadong Medicine Co., Ltd	40.39 Billion CNY	97.035%
Jiangsu Nhwa Pharmaceutical Co., LTD	4.97 Billion CNY	75.921%
Harbin Medisan Pharmaceutical Co., Ltd.	1.18 Billion CNY	-0.908%
LanZhou Foci Pharmaceutical Co.,Ltd.	1.16 Billion CNY	-2.96%
Tianjin Chase Sun Pharmaceutical Co.,Ltd	6.12 Billion CNY	80.455%
Beijing Beilu Pharmaceutical Co., Ltd	890.71 Million CNY	-34.449%
Nanjing Hicin Pharmaceutical Co., Ltd.	517.83 Million CNY	-131.265%
Renhe Pharmacy Co., Ltd.	5.03 Billion CNY	76.202%
Chongqing Pharscin Pharmaceutical Co., Ltd.	691.54 Million CNY	-73.173%
Zhejiang Xianju Pharmaceutical Co.,Ltd.	4.12 Billion CNY	70.957%
Luoxin Pharmaceuticals Group Stock Co., Ltd.	2.34 Billion CNY	48.879%
Guizhou Bailing Group Pharmaceutical Co., Ltd.	4.26 Billion CNY	71.908%

Global Stocks Search

Changjiang Pharmaceutical Group Co., Ltd. (300391.SZ)

Revenue Summary of Changjiang Pharmaceutical Group Co., Ltd.

Annual Revenue Chart of Changjiang Pharmaceutical Group Co., Ltd. (2023 - 2009)

Historical Annual Revenue of Changjiang Pharmaceutical Group Co., Ltd. (2023 - 2009)

Peer Revenue Comparison of Changjiang Pharmaceutical Group Co., Ltd.